Uncertainties of routine HLA B*5701 testing in black African HIV cohorts in the UK.
Sadiq
S T
ST
St George's University of London, London, UK.
Pakianathan
M
M
D019380:Anti-HIV Agents / Q000009:adverse effects*; D044383:Black People / Q000235:genetics*; D015331:Cohort Studies; D015224:Dideoxynucleosides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000235:genetics; D004739:England / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology*; D015235:HLA-B Antigens / Q000302:isolation & purification*; D059950:HLA-B52 Antigen; D006801:Humans; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D015235:HLA-B Antigens; D059950:HLA-B52 Antigen; D000099227:Abacavir; C501279:HLA-B*52:01 antigen